Join us for a discussion with Dr. John L. Jefferies about heart failure drug Entresto and potential use for this drug as a therapy for those who have Barth syndrome. Dr. John L. Jefferies is the appointed Jay M. Sullivan Endowed Chair in Cardiovascular Medicine and Chief of Cardiology at the University of Tennessee Health Science Center (UTHSC) as well as the co-director for the newly formed UT Methodist Institute for Cardiovascular Science. Prior to UT, John spent more than eight years with the University of Cincinnati College of Medicine and Cincinnati Children’s, where he was an associate professor of adult cardiovascular disease and pediatric cardiology from 2010-2015, professor of adult cardiovascular disease and pediatric cardiology from 2015-2018, and professor of human genetics from 2015-2018. Of immense value to our community, John was the Director of the Advanced Heart Failure and Cardiomyopathy Services in the Heart Institute at Cincinnati Children’s Hospital Medical Center, where he played a primary role in BTHS patient heart transplantation cases.
-to educate the audience on the current indications for the use of Entresto in heart failure populations
-to discuss cardiovascular pathophysiology that occurs in patients with Barth syndrome
-to identify potential clinical and research opportunities for the use of Entresto in the Barth syndrome population